Literature DB >> 6932952

Variation in sensitivity of DNA synthesis to ara-C in acute myeloid leukaemia.

A L Harris, D G Grahame-Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6932952     DOI： 10.1111/j.1365-2141.1980.tb07157.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukaemia.

Authors:  A L Harris; D G Grahame-Smith
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Clinical trial of low-dose Ara-C in the treatment of acute leukemia and myelodysplasia.

Authors:  U Jehn; R De Bock; C Haanen
Journal:  Blut       Date:  1984-05

3.  In vitro exposure of leukemic cells to low concentration Arabinosyl Cytosine: no evidence of differentiation inducing activity.

Authors:  M R Motta; M Baccarani; S Rizzi; R Fanin; G Fasola; C Poluzzi; S Tura
Journal:  Blut       Date:  1987-05

4.  Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside.

Authors:  L M DeAngelis; W Kreis; K Chan; E Dantis; S Akerman
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine.

Authors:  R Grunewald; J L Abbruzzese; P Tarassoff; W Plunkett
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  Clinical pharmacology of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in patients with hematologic malignancies.

Authors:  T Ueda; T Nakamura; D Kagawa; M Uchida; N Domae; M Sugiyama; Y Ueda; M Sasada; H Uchino
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Retrospective comparison of fludarabine in combination with intermediate-dose cytarabine versus high-dose cytarabine as consolidation therapies for acute myeloid leukemia.

Authors:  Wenjun Zhang; Yi Ding; Hao Wu; Yuhua Chen; Huina Lu; Chunying Chen; Jianfei Fu; Weiguang Wang; Aibin Liang; Shanhua Zou
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

Review 8.  Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action.

Authors:  Ellen J B Derissen; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2020-12       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.